Why Figs Stock Popped Today

Figs (FIGS) stock rose 7.8% after Q3 earnings beat estimates, with revenue up 26% YoY to $190.7M and EPS at $0.10. Core scrubs sales grew 24%, while non-scrubwear and international sales saw faster growth. Profit margins expanded to 10.1%. CEO Trina Spear expects momentum into 2027, but Q4 growth forecast is slower at 15%.

Original reporting
Published Nov 9, 2026, 3:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 4:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Figs Stock Popped Today — source image
Decision brief

The 30-second read

$FIGSBullishHigh
01

Why it matters

The earnings beat provides a fresh catalyst for short-term buying, though cautious Q4 outlook may limit upside.

02

Market read

Earnings surprise creates immediate trading opportunity; sector peers may benefit from positive sentiment.

03

What to watch

International sales surge and new product lines may drive longer-term growth beyond the guidance.

Relevance 8/10Novelty 8/10Timing: morning trade today

Background

Figs, a medical scrubs supplier, reported Q3 results that beat estimates, prompting a sharp intraday rally.

Company-level read

Ticker impact

$FIGSBullishHigh confidence
Context

Q3 earnings beat revenue and EPS estimates, with sales up 26% YoY, driving a 7.8% intraday rally.

Expected impact

likely upward pressure as traders price in the earnings beat despite cautious guidance

Evidence & confidence

Strong top-line growth and profit margin expansion are positive, while guidance slowdown introduces some caution.

Market effects

Highlights robust demand for medical apparel, potentially boosting peers in healthcare supplies.

U.S. healthcare sector may see modest uplift as investors reassess earnings expectations.

Limited to U.S. market; no broader macro implications.

Counterpoint

Guidance slowdown could signal a near-term earnings plateau, prompting profit-taking.

Key entities

  • Figs

    Medical apparel supplier listed on NYSE.

Related articles

$FIGSHighAI 8/10

Cantor Fitzgerald initiates Figs stock with overweight rating

Cantor Fitzgerald initiated coverage on Figs Inc. (NYSE:FIGS) with an overweight rating and a $25.00 price target. The stock trades at $21.58 with a $3.58B market cap. Figs reported Q3 2026 core scrubs sales of $191M, up 26%, and raised fiscal 2026 sales guidance to 23.5%. The company's gross profit margin is 67.73%, and adjusted EBITDA margin is projected to rise to 18.4% by fiscal 2028. FIGS shares declined in after-hours trading despite beating earnings expectations.

$FIGSMed

What FIGS (FIGS) Said on Its Q3 Earnings Call

FIGS reported Q3 revenue of $190.7M, up 21% in the U.S. and 51% internationally. Gross margin was 69.3%, down 60 bps but above expectations. Adjusted EBITDA margin rose to 16.5%. The company raised its full-year 2026 revenue growth forecast to 23.5% and adjusted its margin outlooks. FIGS faces supply chain challenges but expects to expand production capacity in Indonesia by 2027. Inventory fell 20% YoY to $121.3M.

$FIGSHighAI 8/10

FIGS Inc (FIGS) (Q3 2026) Earnings Call Highlights: Revenue Surges 26% as International

FIGS Inc reported Q3 2026 revenue of $190M, up 26% YoY, beating guidance despite supply constraints. CEO Trina Spear highlighted strong US growth, driven by e-commerce and hubs/Teams. CFO Sarah Altred cited revenue leverage, marketing efficiencies, and improved product mix for margin expansion. The company expects continued growth in 2027, with international markets and new categories like 'the Charmacy' as key drivers.

$FIGSHigh

FIGS Releases Third Quarter 2026 Financial Results

FIGS, Inc. (FIGS) filed an SEC Form 8-K — Results of Operations and Financial Condition. FIGS Releases Third Quarter 2026 Financial Results Exceeded Top and Bottom Line Expectations Grew Net Revenues 25.7% Achieved Net Income Margin of 10.1% and Adjusted EBITDA Margin of 16.5% Increasing Full Year 2026 Outlook SANTA MONICA, Calif., November 5, 2026 — FIGS, Inc. (NYSE